Literature DB >> 19377510

Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals.

E Giannoni1, T Fiaschi, G Ramponi, P Chiarugi.   

Abstract

Resistance to detachment-induced apoptosis, a process commonly referred as anoikis, is emerging as a hallmark of metastatic malignancies, mainly because it can ensure anchorage-independent growth and survival during organ colonization. Besides, a sustained oxidative stress has been associated with several steps of carcinogenesis, including transformation and achievement of a motile mesenchymal phenotype. Here, we demonstrate that metastatic prostate carcinoma cells, undergoing a constitutive deregulated production of reactive oxygen species due to sustained activation of 5-lipoxygenase, lack suicidal pathways in response to lack of matrix contact. These amplified and persistent redox signals in PC3 cells leads to maintenance of Src oxidation and activation in the absence of adhesion, thereby sustaining a ligand-independent phosphorylation of epidermal growth factor receptor. This leads to chronic activation of pro-survival signals, culminating in degradation of the pro-apoptotic protein Bim, thereby promoting cell survival even in the absence of proper adhesion. Anoikis sensitivity of metastatic cells is restored with antioxidant intervention or genetic manipulation of the redox-mediated pro-survival pathway, as well as exposure to a pro-oxidant environment strongly increases anoikis resistance in non-transformed prostate epithelial cells. Hence, our results allow new insight into the aetiology of the molecular mechanisms granting anoikis resistance of metastatic cancers, opening new avenues to pharmacological intervention for antioxidant-sensitive invasive tumours.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377510     DOI: 10.1038/onc.2009.77

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

Review 1.  Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.

Authors:  Simeng Wen; Yuanjie Niu; Soo Ok Lee; Chawnshang Chang
Journal:  Cancer Treat Rev       Date:  2013-08-07       Impact factor: 12.111

Review 2.  Mitochondrial ROS and cancer drug resistance: Implications for therapy.

Authors:  Imoh S Okon; Ming-Hui Zou
Journal:  Pharmacol Res       Date:  2015-08-11       Impact factor: 7.658

3.  ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.

Authors:  Keneshia K Haenssen; Sarah A Caldwell; Kristina S Shahriari; S Raelle Jackson; Kelly A Whelan; Andres J Klein-Szanto; Mauricio J Reginato
Journal:  J Cell Sci       Date:  2010-03-23       Impact factor: 5.285

4.  Matrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cells.

Authors:  Stephanie M Wittig-Blaich; Lukasz A Kacprzyk; Thorsten Eismann; Melanie Bewerunge-Hudler; Petra Kruse; Eva Winkler; Wolfgang S L Strauss; Raimund Hibst; Rudolf Steiner; Mark Schrader; Daniel Mertens; Holger Sültmann; Rainer Wittig
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

Review 5.  ROS in Cancer: The Burning Question.

Authors:  Iok In Christine Chio; David A Tuveson
Journal:  Trends Mol Med       Date:  2017-04-17       Impact factor: 11.951

Review 6.  Redox metabolism and malignancy.

Authors:  Christina L Grek; Kenneth D Tew
Journal:  Curr Opin Pharmacol       Date:  2010-06-04       Impact factor: 5.547

7.  Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.

Authors:  Xiaoping He; Takayo Ota; Peng Liu; Changqing Su; Jeremy Chien; Viji Shridhar
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

8.  PGE2 /EP4 receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy.

Authors:  Siwei Tan; Xiaoliang Chen; Minyi Xu; Xiaoli Huang; Huiling Liu; Jie Jiang; Yu Lu; Xiaojie Peng; Bin Wu
Journal:  Br J Pharmacol       Date:  2017-03-25       Impact factor: 8.739

Review 9.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

10.  Scavenging of reactive oxygen and nitrogen species with nanomaterials.

Authors:  Carolina A Ferreira; Dalong Ni; Zachary T Rosenkrans; Weibo Cai
Journal:  Nano Res       Date:  2018-05-26       Impact factor: 8.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.